NCT07915323
PET Imaging of the sigma1 Receptor in Healthy Adults
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Test-Blocking measurements, based on quantitative analysis of PET imaging data.
Timeframe: 4 years
Arms and interventions
Test/blocking PET scans for healthy controlsExperimental
A test-blocking study to assess specific binding levels of (S)-\[18F\] FBFP or (R)-\[18F\]FBFP in humans. A total of 10 healthy subjects will undergo two PET scans on two separate days, with the second scan at 4 h (Tmax) after an oral dose of 10 mg donepezil. Each subject will also undergo one MRI scan for anatomical identification of brain regions.
Drugs: (S)-[18F] FBFP or (R)-[18F]FBFP
Sites
1 site in 1 country
- Yale University PET CenterNew Haven, Connecticut, United States